{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:27:14Z","timestamp":1789014434617,"version":"build-2803163510"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"AT Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Ataxia-Telangiectasia (A-T) is a genetic condition leading to neurological defects and immune deficiency. The nature of the immune deficiency is highly variable, and in some cases causes significant morbidity and mortality due to recurrent sinopulmonary infections. Although the neurological defects in A-T are progressive, the natural history of the immune deficiency in A-T has not been evaluated formally. In this study we analyse the clinical history and immunological data in 44 patients with A-T who attended the National Ataxia-Telangiectasia clinic in Nottingham between 2001 and 2011. Using patient medical records and Nottingham University Hospitals (NUH) National Health Service Trust medical IT systems, data regarding clinical history, use of immunoglobulin replacement therapy, total immunoglobulin levels, specific antibody levels and lymphocyte subset counts were obtained. T cell receptor spectratyping results in some patients were already available and, where possible, repeat blood samples were collected for analysis. This study shows that subtle quantitative changes in certain immunological parameters such as lymphocyte subset counts may occur in patients with A-T over time. However, in general, for the majority of patients the severity of immune deficiency (both clinically and in terms of immunological blood markers) does not seem to deteriorate significantly with time. This finding serves to inform the long-term management of this cohort of patients because, if recurrent respiratory tract infections present later in life, then other contributory factors (e.g. cough\/swallowing difficulties, underlying lung disease) should be investigated aggressively. Our findings also offer some form of reassurance for parents of children with A-T, which is otherwise a progressively severely debilitating condition.<\/jats:p>","DOI":"10.1111\/cei.12262","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T11:07:15Z","timestamp":1389006435000},"page":"275-282","source":"Crossref","is-referenced-by-count":49,"title":["Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients"],"prefix":"10.1093","volume":"176","author":[{"given":"C","family":"Chopra","sequence":"first","affiliation":[{"name":"Immunology Department, Queen's Medical Centre, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Davies","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital and Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Taylor","sequence":"additional","affiliation":[{"name":"CR\u2013UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Anderson","sequence":"additional","affiliation":[{"name":"Royal Victoria Infirmary, Newcastle Upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bainbridge","sequence":"additional","affiliation":[{"name":"University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tighe","sequence":"additional","affiliation":[{"name":"University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"McDermott","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"2021122010024934900_cei12262-bib-0001","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-pathol-011811-132509","article-title":"ATM and the molecular pathogenesis of Ataxia-Telangiectasia","volume":"7","author":"McKinnon","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"2021122010024934900_cei12262-bib-0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2021122010024934900_cei12262-bib-0003","first-page":"320","article-title":"Mutations associated with variant phenotypes in Ataxia-telangiectasia","volume":"59","author":"McConville","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2021122010024934900_cei12262-bib-0004","doi-asserted-by":"crossref","first-page":"30133","DOI":"10.1074\/jbc.M103160200","article-title":"Residual Ataxia-Telangiectasia mutated protein function in cells from Ataxia-Telangiectasia patients, with 5762ins137 and 7271T \u2013 &gt;G mutations, showing a less severe phenotype","volume":"276","author":"Stewart","year":"2001","journal-title":"J Biol Chem"},{"key":"2021122010024934900_cei12262-bib-0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","article-title":"Immunodeficiency in Ataxia-Telangiectasia is correlated strongly with the presence of two null mutations in the Ataxia-Telangiectasia mutated gene","volume":"153","author":"Staples","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2021122010024934900_cei12262-bib-0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in Ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J Pediatr"},{"key":"2021122010024934900_cei12262-bib-0007","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.1982.03330110042023","article-title":"Fetal proteins in Ataxia-Telangiectasia","volume":"248","author":"Richikind","year":"1982","journal-title":"JAMA"},{"key":"2021122010024934900_cei12262-bib-0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2011.03.007","article-title":"Premature ageing of the immune system underlies immunodeficiency in Ataxia-Telangiectasia","volume":"140","author":"Exley","year":"2011","journal-title":"Clin Immunol"},{"key":"2021122010024934900_cei12262-bib-0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00918137","article-title":"Selective deficiency of CD4+\/CD45RA+ lymphocytes in patients with Ataxia-Telangiectasia","volume":"12","author":"Paganelli","year":"1992","journal-title":"J Clin Immunol"},{"key":"2021122010024934900_cei12262-bib-0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2249.2002.01830.x","article-title":"Deficiencies in CD4+ and CD8+ T cell subsets in Ataxia-Telangiectasia","volume":"129","author":"Schubert","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2021122010024934900_cei12262-bib-0011","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000023951","article-title":"Serum IgD concentrations in patients with Ataxia-Telangiectasia and with selective IgA deficiency","volume":"116","author":"Sanal","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"2021122010024934900_cei12262-bib-0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198203043060905","article-title":"IgG2 deficiency in Ataxia-Telangiectasia","volume":"306","author":"Oxelius","year":"1982","journal-title":"N Engl J Med"},{"key":"2021122010024934900_cei12262-bib-0013","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1023\/A:1020599810261","article-title":"Impaired IgG antibody production to pneumococcal polysaccharides in patients with Ataxia-Telangiectasia","volume":"19","author":"Sanal","year":"1999","journal-title":"J Clin Immunol"},{"key":"2021122010024934900_cei12262-bib-0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2006.04.568","article-title":"Intact T cell responses in Ataxia-Telangiectasia","volume":"120","author":"Pashankar","year":"2006","journal-title":"Clin Immunol"},{"key":"2021122010024934900_cei12262-bib-0015","first-page":"89","article-title":"Mortality and cancer incidence in 263 patients with Ataxia-telangiectasia","volume":"77","author":"Morrell","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"2021122010024934900_cei12262-bib-0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(02)00004-2","article-title":"Combination of MHC-peptide multimer-based T-cell sorting with the immunoscope permits sensitive ex vivo quantitation and follow up of human CD8+ T-cell responses","volume":"261","author":"Lim","year":"2002","journal-title":"J Immunol Methods"},{"key":"2021122010024934900_cei12262-bib-0017","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/eci.09.35","article-title":"Update on the management of the immunodeficiency in Ataxia-telangiectasia","volume":"5","author":"Davies","year":"2009","journal-title":"Exp Rev Clin Immunol"},{"key":"2021122010024934900_cei12262-bib-0018","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.2006.094268","article-title":"Survival probability in Ataxia-Telangiectasia","volume":"91","author":"Crawford","year":"2006","journal-title":"Arch Dis Child"},{"key":"2021122010024934900_cei12262-bib-0019","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from Ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12262","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/2\/275\/41789804\/cei12262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/2\/275\/41789804\/cei12262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:54Z","timestamp":1641054354000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/176\/2\/275\/6421171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4,9]]},"published-print":{"date-parts":[[2014,4,9]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12262","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,4,9]]}}}